Preventable effects of bare-metal stent on restenosis after everolimus-eluting stent deployment

[1] Yamawaki M(2002)Randomized study with the Sirolimus-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 1773-1780

[2] Onuma Y(2014)Simultaneous occlusion of left anterior descending and left circumflex arteries by very late stent thrombosis: vascular response to drug-eluting stents assessed by intravascular ultrasound Heart Vessels 1 58-65

[3] Nakano M(2005)A randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial EuroIntervention 107 833-840

[4] Muramatsu T(2011)Long-term (three-year) safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents (from the SPIRIT III Trial) Am J Cardiol 109 2500-2502

[5] Nakatani S(2004)Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes Circulation 123 2954-2963

[6] Ishibashi Y(2011)Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation Circulation 70 515-523

[7] Ishimori H(2007)Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials Catheter Cardiovasc Interv 21 26-34

[8] Hirano K(1993)Quantitative analysis of elastic recoil after balloon angioplasty and after intracoronary implantation of balloon-expandable Palmaz-Schatz stents J Am Coll Cardiol 144 132-134

[9] Ito Y(2010)Incidence of diffuse and focal chronic stent recoil after implantation of current generation bare-metal and drug-eluting stents Int J Cardiol 102 357-358

[10] Tsukahara R(2005)Double-stenting of an ostial left main-stem lesion for elastic recoil Int J Cardiol 15 39-44

[1] Yamawaki M(2002)Randomized study with the Sirolimus-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 1773-1780

[2] Onuma Y(2014)Simultaneous occlusion of left anterior descending and left circumflex arteries by very late stent thrombosis: vascular response to drug-eluting stents assessed by intravascular ultrasound Heart Vessels 1 58-65

[3] Nakano M(2005)A randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial EuroIntervention 107 833-840

[4] Muramatsu T(2011)Long-term (three-year) safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents (from the SPIRIT III Trial) Am J Cardiol 109 2500-2502

[5] Nakatani S(2004)Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes Circulation 123 2954-2963

[6] Ishibashi Y(2011)Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation Circulation 70 515-523

[7] Ishimori H(2007)Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials Catheter Cardiovasc Interv 21 26-34

[8] Hirano K(1993)Quantitative analysis of elastic recoil after balloon angioplasty and after intracoronary implantation of balloon-expandable Palmaz-Schatz stents J Am Coll Cardiol 144 132-134

[9] Ito Y(2010)Incidence of diffuse and focal chronic stent recoil after implantation of current generation bare-metal and drug-eluting stents Int J Cardiol 102 357-358

[10] Tsukahara R(2005)Double-stenting of an ostial left main-stem lesion for elastic recoil Int J Cardiol 15 39-44